Research technicians

Jeanelle Tsai, BA, ( works on identifying genes that cause drug resistance in EGFR-mutant NSCLCs using a genome-wide CRISPR activation screening system. She is assessing the efficacy of targeting those genes in vitro with the goal of eliminating minimal residual disease (MRD). 

Portrait of Caitlyn Weston

Caitlyn Weston, BA, ( works on investigating the effects of various RTKi combination treatments in an effort to overcome and prevent acquired resistance to EGFR-targeted therapies in EGFR-mutant NSCLC. She also works on the Cell Establishment Team to process and establish patient and PDX models for in-lab use

Soumya Malhotra, BA, MS (  works on EGFR, ALK, KRAS and ROS mutant NSCLC cell lines with a goal to identify drug therapies targeting persister cells. Soumya also works with patient samples and PDX to develop in vitro 2D and 3D NSCLC models.